12/5
08:08 am
ints
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]
Medium
Report
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]
12/5
08:07 am
ints
Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance [Seeking Alpha]
Medium
Report
Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance [Seeking Alpha]
12/5
07:30 am
ints
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
Medium
Report
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
12/4
07:47 am
ints
Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium
High
Report
Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium
11/6
04:02 pm
ints
Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/31
08:00 am
ints
Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock
High
Report
Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock
9/10
08:22 am
ints
Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update [Yahoo! Finance]
Low
Report
Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update [Yahoo! Finance]
9/10
07:47 am
ints
Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
Medium
Report
Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
5/13/2025
04:06 pm
INTS
intensity therapeutics, inc.
MISS
Report
-5.6%
intensity therapeutics, inc.
12/5
07:33 am
ints
Form 8-K INTENSITY THERAPEUTICS, For: Dec 04
Low
Report
Form 8-K INTENSITY THERAPEUTICS, For: Dec 04
12/4
07:02 am
ints
Form 8-K INTENSITY THERAPEUTICS, For: Dec 04
High
Report
Form 8-K INTENSITY THERAPEUTICS, For: Dec 04
12/4
07:01 am
ints
Form 424B5 INTENSITY THERAPEUTICS,
High
Report
Form 424B5 INTENSITY THERAPEUTICS,
11/6
04:04 pm
ints
Form 8-K INTENSITY THERAPEUTICS, For: Nov 06
Medium
Report
Form 8-K INTENSITY THERAPEUTICS, For: Nov 06
11/6
04:02 pm
ints
Form 10-Q INTENSITY THERAPEUTICS, For: Sep 30
Medium
Report
Form 10-Q INTENSITY THERAPEUTICS, For: Sep 30
11/3
07:30 am
ints
Form 424B5 INTENSITY THERAPEUTICS,
Medium
Report
Form 424B5 INTENSITY THERAPEUTICS,
10/31
04:54 pm
ints
Form 8-K INTENSITY THERAPEUTICS, For: Oct 30
Medium
Report
Form 8-K INTENSITY THERAPEUTICS, For: Oct 30
10/23
04:03 pm
ints
Form 8-K INTENSITY THERAPEUTICS, For: Oct 22
Low
Report
Form 8-K INTENSITY THERAPEUTICS, For: Oct 22
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register